{"id":"https://openalex.org/W4408635366","doi":"https://doi.org/10.3389/fphar.2025.1565890","title":"Editorial: Old drugs: confronting recent advancements and challenges","display_name":"Editorial: Old drugs: confronting recent advancements and challenges","alternate_titles":[],"publication_year":2025,"publication_date":"2025-03-19","ids":{"openalex":"https://openalex.org/W4408635366","doi":"https://doi.org/10.3389/fphar.2025.1565890","pmid":"https://pubmed.ncbi.nlm.nih.gov/40176905","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11961997"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2025.1565890","doi":"https://doi.org/10.3389/fphar.2025.1565890","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2025.1565890","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4408635366"],"child_works_count":0,"type":"editorial","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fphar.2025.1565890","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089979417","display_name":"Anna Wiktorowska\u2010Owczarek","orcid":"https://orcid.org/0000-0003-3452-5748","observed_orcids":["https://orcid.org/0000-0003-3452-5748"]},"institutions":[{"id":"https://openalex.org/I4210122071","display_name":"Medical University of Lodz","ror":"https://ror.org/02t4ekc95","country_code":"PL","type":"education","lineage":["https://openalex.org/I4210122071"]}],"countries":["PL"],"is_corresponding":true,"raw_author_name":"Anna Wiktorowska-Owczarek","raw_affiliation_strings":["Department of Pharmacology and Toxicology, Medical University of Lodz, Lodz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology, Medical University of Lodz, Lodz, Poland","institution_ids":["https://openalex.org/I4210122071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091655269","display_name":"Diego Iacono","orcid":"https://orcid.org/0000-0001-5511-0950","observed_orcids":["https://orcid.org/0000-0001-5511-0950"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]},{"id":"https://openalex.org/I4210137803","display_name":"Biomedical Research Institute","ror":"https://ror.org/03yr0pg70","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210137803"]},{"id":"https://openalex.org/I67339987","display_name":"Atlantic Health System","ror":"https://ror.org/02jz99c72","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I67339987"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diego Iacono","raw_affiliation_strings":["Department of Neurology, Thomas Jefferson University, Philadelphia, PA, United States","Neurodevelopmental Research Lab, Biomedical Research Institute of New Jersey (BRInj), Cedar Knolls, NJ, United States","Neuropathology Research, MidAtlantic Neonatology Associates (MANA)/Biomedical Research Institute of New Jersey (BRInj), Cedar Knolls, NJ, United States","Neuroscience Research MANA, Department of Pediatrics, Atlantic Health System (AHS), Morristown, NJ, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Thomas Jefferson University, Philadelphia, PA, United States","institution_ids":["https://openalex.org/I149251103"]},{"raw_affiliation_string":"Neurodevelopmental Research Lab, Biomedical Research Institute of New Jersey (BRInj), Cedar Knolls, NJ, United States","institution_ids":[]},{"raw_affiliation_string":"Neuropathology Research, MidAtlantic Neonatology Associates (MANA)/Biomedical Research Institute of New Jersey (BRInj), Cedar Knolls, NJ, United States","institution_ids":["https://openalex.org/I4210137803"]},{"raw_affiliation_string":"Neuroscience Research MANA, Department of Pediatrics, Atlantic Health System (AHS), Morristown, NJ, United States","institution_ids":["https://openalex.org/I67339987"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046495473","display_name":"Magdalena Jasi\u0144ska-Stroschein","orcid":"https://orcid.org/0000-0001-6171-0733","observed_orcids":["https://orcid.org/0000-0001-6171-0733"]},"institutions":[{"id":"https://openalex.org/I4210122071","display_name":"Medical University of Lodz","ror":"https://ror.org/02t4ekc95","country_code":"PL","type":"education","lineage":["https://openalex.org/I4210122071"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Magdalena Jasi\u0144ska-Stroschein","raw_affiliation_strings":["Department of Biopharmacy, Medical University of Lodz, Lodz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biopharmacy, Medical University of Lodz, Lodz, Poland","institution_ids":["https://openalex.org/I4210122071"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5089979417"],"corresponding_institution_ids":["https://openalex.org/I4210122071"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":null,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":null,"first_page":"1565890","last_page":"1565890"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.8065999746322632,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.8065999746322632,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.022600000724196434,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.020999999716877937,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.996999979019165},{"id":"https://openalex.org/keywords/off-target-effects","display_name":"off-target effects","score":0.8450000286102295},{"id":"https://openalex.org/keywords/age-related-diseases","display_name":"age-related diseases","score":0.6330000162124634},{"id":"https://openalex.org/keywords/chronic-degenerative-diseases","display_name":"chronic degenerative diseases","score":0.6299999952316284},{"id":"https://openalex.org/keywords/artificial-intelligence-in-drug-discovery","display_name":"artificial intelligence in drug discovery","score":0.7129999995231628},{"id":"https://openalex.org/keywords/drug-protein-interactions","display_name":"drug-protein interactions","score":0.6940000057220459},{"id":"https://openalex.org/keywords/parainfluenza-virus-type-3","display_name":"parainfluenza virus type 3","score":0.7950000166893005},{"id":"https://openalex.org/keywords/antiviral-drug-candidates","display_name":"antiviral drug candidates","score":0.5799999833106995},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.503000020980835},{"id":"https://openalex.org/keywords/alzheimer-s-disease-risk-factors","display_name":"Alzheimer's disease risk factors","score":0.3230000138282776},{"id":"https://openalex.org/keywords/alzheimer-s-disease-biomarkers","display_name":"Alzheimer's disease biomarkers","score":0.4350000023841858},{"id":"https://openalex.org/keywords/alzheimer-s-disease-treatment","display_name":"Alzheimer's disease treatment","score":0.4099999964237213},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.4580000042915344},{"id":"https://openalex.org/keywords/parkinson-s-disease-risk-factors","display_name":"Parkinson's disease risk factors","score":0.503000020980835}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4845110774040222},{"id":"https://openalex.org/C55587333","wikidata":"https://www.wikidata.org/wiki/Q1133029","display_name":"Engineering ethics","level":1,"score":0.3805494010448456},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3409305810928345},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.16254132986068726}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.3389/fphar.2025.1565890","doi":"https://doi.org/10.3389/fphar.2025.1565890","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2025.1565890","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11961997","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11961997/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11961997/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:10775479","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11961997","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:40176905","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40176905","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Editorial"},{"id":"pmh:oai:jdc.jefferson.edu:neurologyfp-1366","doi":null,"is_oa":true,"landing_page_url":"https://jdc.jefferson.edu/neurologyfp/359","pdf_url":null,"source":{"id":"https://openalex.org/S4210178181","display_name":"The Medicine Forum","issn_l":"2325-2863","issn":["2325-2863"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Department of Neurology Faculty Papers","raw_type":"editorial"},{"id":"pmh:oai:doaj.org/article:6a32069c043e4002a28f2ba9aacc5787","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/6a32069c043e4002a28f2ba9aacc5787","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 16 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2025.1565890","doi":"https://doi.org/10.3389/fphar.2025.1565890","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2025.1565890","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320323344","display_name":"Uniwersytet \u0141\u00f3dzki","ror":"https://ror.org/05cq64r17"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4408635366.pdf","grobid_xml":"https://content.openalex.org/works/W4408635366.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W630657035","https://openalex.org/W1979026577","https://openalex.org/W2037022423","https://openalex.org/W2047591801","https://openalex.org/W3158101504","https://openalex.org/W4406913933"],"related_works":["https://openalex.org/W7169811691","https://openalex.org/W3046087585","https://openalex.org/W7221300181","https://openalex.org/W7083672163","https://openalex.org/W7106210461","https://openalex.org/W7140938536","https://openalex.org/W7222012454","https://openalex.org/W7153630761","https://openalex.org/W3157365413","https://openalex.org/W7130824738"],"abstract_inverted_index":{"IntroductionDrug":[0],"repurposing":[1,58,107,134,376,692,739,918,941,1102,1124],"involves":[2],"leveraging":[3],"existing":[4,1232],"drugs":[5,67,84,300,348,696,917,997,1008,1233,1255,1432],"or":[6,19,30,39,50,95,274,713,772,1071,1188,1202,1292,1309,1322,1341],"drug":[7,57,88,172,218,240,375,418,438,497,638,741,888,940,970,1026,1069,1101,1225],"candidates,":[8],"originally":[9],"developed":[10],"for":[11,72,133,212,250,253,362,365,446,454,519,545,604,616,749,762,868,939,942,976,1007,1029,1051,1109,1123,1148,1162,1227,1245,1256,1312,1324,1391,1429,1446,1470],"other":[12,617],"conditions,":[13,557],"to":[14,46,93,123,145,227,235,284,287,293,298,420,479,643,666,697,708,724,786,833,857,862,864,1067,1072,1221,1279,1354,1466],"address":[15],"new":[16,233,314,354,457,540,1106,1248,1273,1314],"therapeutic":[17,974,991,1013,1107,1249,1438,1444],"purposes":[18],"medical":[20,127,157],"conditions.":[21,52],"This":[22,256,703,986,1411],"strategy":[23],"often":[24],"draws":[25],"from":[26,843,1009,1433],"observations":[27],"of":[28,56,272,279,303,316,321,414,469,506,522,531,536,607,621,691,694,734,765,810,813,837,841,887,891,895,898,911,916,922,969,979,1012,1088,1100,1125,1137,1184,1190,1197,1215,1254,1272,1301,1304,1361,1365,1402,1420,1437],"unintended":[29],"off-target":[31],"effects,":[32],"including":[33,141,331,378,558,795,945,1015],"those":[34],"initially":[35,1489],"seen":[36],"as":[37,62,156,384,395,926,1039,1041,1121,1143,1395,1397],"adverse":[38],"age-specific,":[40],"which":[41,404,461,610,1447,1475],"may":[42,59,1211,1297],"reveal":[43],"their":[44,788,827,1043,1468],"potential":[45,186,423,437,456,968,1060,1318,1469],"alleviate":[47],"chronic,":[48],"degenerative,":[49],"age-related":[51],"The":[53,117,324,370,600,653,729,775,805,839,1021,1153,1251],"core":[54],"characteristics":[55],"be":[60,236,613,1119,1298],"summarized":[61],"follows:1.":[63],"Well-Known":[64],"Safety:":[65],"Repurposed":[66],"are":[68,902,998,1205,1327,1464],"typically":[69],"already":[70,1290],"tested":[71,625],"safety":[73,276,1364,1484],"in":[74,174,225,238,247,318,353,403,449,466,484,533,551,626,640,663,670,738,768,792,879,919,1076,1092,1269,1284,1286,1330,1359,1375,1417,1424,1456,1476],"humans,":[75],"significantly":[76],"reducing":[77,562],"early-stage":[78],"development":[79,105,1271],"risks.2.":[80],"Streamlined":[81],"Development:":[82],"These":[83,525],"can":[85,1032,1118,1266],"bypass":[86],"initial":[87],"discovery":[89,219],"phases,":[90],"proceeding":[91],"directly":[92],"preclinical":[94,1457],"clinical":[96,447,736,848,866,1333,1373,1404,1462,1473],"trials.3.":[97],"Cost":[98],"and":[99,112,138,148,162,179,197,216,224,266,268,381,390,399,416,514,578,597,669,674,681,720,747,781,799,819,825,846,882,893,900,914,929,951,1018,1036,1151,1182,1195,1217,1238,1263,1265,1295,1363,1370,1382,1400,1460,1485],"Risk":[100],"Reduction:":[101],"By":[102],"skipping":[103],"early":[104],"stages,":[106],"lowers":[108],"both":[109,1149],"financial":[110,952,1350],"costs":[111],"associated":[113,875],"risks.4.":[114],"Time":[115],"Efficiency:":[116],"process":[118],"offers":[119],"a":[120,213,243,455,463,539,568,574,659,908,1010,1079,1157,1213,1235,1313,1434,1472],"quicker":[121],"path":[122],"market,":[124],"addressing":[125],"unmet":[126],"needs":[128],"efficiently.More":[129],"recently,":[130],"the":[131,200,204,248,270,280,295,308,319,336,343,407,411,417,422,427,435,467,516,520,528,534,552,605,622,627,631,641,689,727,755,760,763,784,811,822,830,834,851,855,933,946,955,961,967,977,990,1049,1057,1068,1073,1085,1132,1135,1168,1171,1176,1198,1270,1302,1317,1331,1356,1418,1421,1427,1442],"search":[132,249],"candidates":[135,1028,1062,1122,1226],"combines":[136],"traditional":[137],"modern":[139],"tools,":[140],"but":[142,291,351,1367,1377],"not":[143],"limited":[144],"computational":[146],"analysis":[147,386],"database":[149],"searches":[150],"(i.e.":[151],"utilizing":[152],"public":[153,1393],"databases":[154],"such":[155,925,1403,1471],"journals,":[158],"regulatory":[159,1307],"agency":[160],"archives,":[161],"patient":[163],"advocacy":[164],"group":[165],"reports);":[166],"newer":[167],"experimental":[168],"approaches":[169],"(i.e.,":[170,182],"testing":[171],"interactions":[173],"novel":[175,1319],"contexts);":[176],"artificial":[177],"intelligence":[178],"bioinformatics":[180],"tools":[181],"advanced":[183],"algorithms":[184],"explore":[185],"drug-protein":[187],"interactions,":[188],"integrating":[189],"pharmacological":[190,1237],"data":[191,965],"with":[192,672,876,1000,1234,1289],"genetics,":[193],"pharmacogenomics,":[194],"biological":[195],"pathways,":[196],"diagnostic/prognostic":[198],"insights).For":[199],"above":[201],"reasons,":[202],"over":[203,307],"years,":[205],"there":[206],"has":[207,305,476,542,573,587,1023],"been":[208,477,543,1454],"an":[209,373,636,752,808,1144,1242],"increasing":[210],"demand":[211],"more":[214],"effective":[215,251],"cost-efficient":[217],"process.":[220],"To":[221],"do":[222],"so":[223],"addition":[226],"searching":[228],"for.":[229],"In":[230,954,1078,1130,1167],"review":[231,299,329,686,705,840,910,987,1022,1170,1218],"entirely":[232],"molecules":[234],"included":[237],"therapies,":[239],"repositioning":[241,971,1027,1229,1430],"is":[242,258,434,462,567,1156,1241,1345,1352],"dynamically":[244],"developing":[245],"area":[246,1445],"therapy":[252],"many":[254,555,1425],"diseases.":[255,323],"approach":[257],"actually":[259],"particularly":[260],"appealing":[261],"since":[262],"it":[263,603],"saves":[264],"time":[265,890],"resources":[267],"reduces":[269,592],"risk":[271,1058],"failure":[273],"unexpected":[275],"issues.The":[277],"aim":[278],"special":[281,1209],"issue":[282,1210],"was":[283,459,677],"inspire":[285],"you":[286],"present":[288],"your":[289],"research,":[290],"also":[292,612,731,988,1104],"encourage":[294],"interested":[296,1283],"readers":[297],"whose":[301],"scope":[302],"action":[304],"expanded":[306],"years":[309],"and,":[310],"additionally,":[311],"open":[312],"up":[313],"points":[315],"entry":[317],"treatment":[320,364,468,535,818,892,978],"various":[322,973,1366],"research":[325,341,586,624,912,1288,1338,1405],"topic":[326],"features":[327],"six":[328],"articles,":[330],"one":[332],"systemic":[333],"review.":[334],"Additionally,":[335],"collection":[337,1214],"includes":[338],"four":[339],"original":[340,344,623,1216,1443],"papers.In":[342],"papers,":[345],"commonly":[346],"known":[347],"were":[349,873,1096,1450],"analyzed,":[350],"contextualized":[352],"applications.":[355],"For":[356],"example,":[357],"Chen":[358],"et":[359,472,487,492,584,651,701,803,905,959,1083,1113,1408,1496],"al.":[360,493,585,652,906,1114,1409],"searched":[361],"antiviral":[363],"parainfluenza":[366],"3":[367],"(PIV3)":[368],"illness.":[369],"authors":[371,601,654,730,806,856,934,962,1047,1133,1172,1389],"explored":[372,989],"integrated":[374],"method,":[377,429],"disease":[379,412,1127],"similarity":[380,383],"chemical":[382],"multi-similarity":[385],"approaches,":[387,398],"molecular":[388,391,1146],"docking":[389],"dynamic":[392],"simulation":[393],"methods":[394],"structure-based":[396],"screening":[397],"network":[400,408],"proximity":[401],"analysis,":[402],"they":[405,430,442,1117],"quantified":[406],"distance":[409],"between":[410,1179],"module":[413],"PIV3":[415],"targets":[419],"probe":[421],"anti-PIV3":[424],"drugs.":[425,1111,1274],"Using":[426],"aforementioned":[428],"confirmed":[431],"that":[432,589,656,754,859,993,1025,1059,1116,1207,1348,1423,1488],"oseltamivir":[433,445],"best":[436],"against":[439,554],"PIV3.":[440],"Therefore,":[441],"recommend":[443],"considering":[444],"application":[448],"children.The":[450],"next":[451],"compound":[452],"analyzed":[453],"indication":[458],"rosiglitazone,":[460],"thiazolidinedione":[464],"used":[465,1075],"diabetes":[470],"(Lehmann":[471],"al.,":[473,488,960,1084,1497],"1995).":[474],"Rosiglitazone":[475],"reported":[478],"ameliorate":[480],"high-fat":[481],"diet-induced":[482],"obesity":[483],"mice":[485,671],"(Petrovic":[486],"2010).":[489],"As":[490],"Li":[491],"showed,":[494],"this":[495,675,1054,1208,1296],"antidiabetic":[496,719],"promotes":[498],"adipocyte":[499],"browning":[500,523],"by":[501,508,561,679,779,957,983,1081,1337],"inhibiting":[502],"autophagy.More":[503],"specifically,":[504],"inhibition":[505,1183],"autophagy":[507],"rosiglitazone":[509,532],"increased":[510,1398,1486],"p62":[511],"nuclear":[512],"translocation":[513],"stabilized":[515],"PPAR\u03b3-RXR\u03b1":[517],"heterodimer":[518],"transcription":[521],"genes.":[524],"studies":[526,1003,1458],"underlined":[527],"promising":[529],"role":[530,1136],"obesity.":[537],"Interestingly,":[538],"challenge":[541],"set":[544],"dexmedetomidine":[546],"(DEX),":[547],"namely":[548],"its":[549],"participation":[550],"protection":[553,1308],"degenerative":[556],"neurodegenerative":[559],"diseases,":[560],"oxidative":[563,593],"stress.":[564],"Indeed,":[565],"DEX":[566,590],"highly":[569],"selective":[570],"\u03b12-adrenoceptors":[571],"agonist,":[572],"sedative,":[575],"analgesic":[576],"effect":[577,693],"anti-sympathetic":[579],"properties":[580],"(Keating,":[581],"2015).":[582],"Lou":[583],"shown":[588,1024],"effectively":[591],"stress,":[594],"avoids":[595],"apoptosis":[596],"protects":[598],"osteoblasts.":[599],"propose":[602],"prevention":[606],"bone":[608],"defects,":[609],"could":[611,1479],"utilized":[614],"though":[615],"non-bone":[618],"defects.The":[619],"last":[620],"diabetic":[628,714],"retinopathy":[629],"(DR)":[630],"purine":[632],"analogue":[633],"6-thioguanine":[634],"(6TG),":[635],"old":[637,1325,1431],"approved":[639,1291,1451],"60s":[642],"treat":[644],"acute":[645],"myeloid":[646],"leukemia":[647],"(AML)":[648],"\u2013":[649],"Trotta":[650],"concluded":[655],"6TG":[657],"revealed":[658],"marked":[660],"anti-angiogenic":[661],"activity":[662,676],"HUVECs":[664],"exposed":[665],"high":[667],"glucose":[668],"DR,":[673],"mediated":[678],"MC1R":[680],"MC5R":[682],"retinal":[683],"receptors.In":[684],"turn,":[685],"papers":[687],"considered":[688],"possibility":[690],"cardiovascular-metabolic":[695],"prolong":[698],"life":[699],"(Barinda":[700],"al.).":[702,804],"systematic":[704],"mainly":[706,1173,1328],"addressed":[707,936],"animal":[709],"models":[710],"(short-lived,":[711],"obese":[712],"mice),":[715],"where":[716],"numerous":[717],"cardiovascular,":[718],"lipid-lowering":[721],"medications":[722,767,1326],"proved":[723],"successfully":[725],"extend":[726],"lifespan.":[728],"provide":[732,1481],"summary":[733],"ongoing":[735],"trial":[737],"cardiometabolic":[740],"(metformin,":[742],"omega-3":[743],"fatty":[744],"acid,":[745],"acarbose,":[746],"atorvastatin)":[748],"aging,":[750],"expressing":[751],"expectation":[753],"obtained":[756],"findings":[757,842],"will":[758],"give":[759],"support":[761,1351],"utility":[764],"these":[766,814,996],"healthy":[769],"subjects\u2019":[770],"cardiovascular":[771],"neurological":[773],"aging.":[774],"pleiotropic":[776],"effects":[777,828,1087],"exerted":[778],"statins":[780,872,901],"beta-blockers":[782],"gave":[783],"rationale":[785],"evaluate":[787],"possible":[789,1177,1357],"complementary":[790],"use":[791,1253],"solid":[793],"tumours,":[794],"breast,":[796,880],"colorectal,":[797,927],"lung,":[798],"prostate":[800,883],"cancers":[801],"(Braga":[802],"provided":[807,907],"update":[809],"impact":[812,1033],"therapies":[815],"on":[816,829,966,1175],"cancer":[817,852,943,1150,1185],"surveillance,":[820],"discussing":[821],"underlying":[823],"mechanisms,":[824],"exploring":[826,1105],"heart,":[831],"contributing":[832],"growing":[835],"field":[836],"cardiooncology.":[838],"retrospective":[844],"analyses,":[845],"randomized":[847,1384],"trials":[849,1334,1463],"within":[850],"continuum":[853],"allowed":[854],"conclude":[858],"\u03b2-blockers":[860,899],"seemed":[861],"lead":[863],"better":[865],"outcomes":[867,878],"breast":[869],"cancer,":[870],"whereas":[871],"positively":[874],"greater":[877],"colorectal":[881],"treatment.":[884],"Further":[885],"evaluations":[886],"dosage,":[889],"benefits":[894],"different":[896,920,1089,1257],"classes":[897,975],"needed,":[903],"however.Fatemi":[904],"comprehensive":[909],"efforts,":[913],"examples":[915],"types":[921],"gastrointestinal":[923],"cancers,":[924],"pancreatic,":[928],"liver":[930],"cancer.":[931,1166],"Moreover,":[932],"have":[935,1453],"several":[937,1223],"barriers":[938],"therapy,":[944],"legal,":[947],"regulatory,":[948],"patent":[949],"issues":[950],"factors.":[953],"work":[956],"Glajzner":[958],"presented":[963],"current":[964,1169],"across":[972],"infectious":[980,1030],"diseases":[981,1031,1258],"caused":[982],"multidrug-resistant":[984],"bacteria.":[985],"possibilities":[992],"arise":[994],"when":[995],"combined":[999],"antibiotics.":[1001],"Preclinical":[1002],"demonstrated":[1004,1455],"considerable":[1005],"promises":[1006,1428],"range":[1011,1436],"areas,":[1014],"oncology,":[1016],"psychiatry,":[1017],"pain":[1019],"management.":[1020],"bacterial":[1034],"metabolism":[1035],"cellular":[1037],"structure,":[1038],"well":[1040,1396],"damage":[1042],"genetic":[1044],"material.":[1045],"However,":[1046],"emphasized":[1048,1134],"need":[1050],"further":[1052,1287,1461],"research;":[1053],"should":[1055],"exclude":[1056],"antibacterial":[1061],"would":[1063],"induce":[1064],"resistance":[1065],"-either":[1066],"itself":[1070],"antibiotics":[1074],"conjunction.":[1077],"mini-review":[1080],"Huang":[1082],"protective":[1086],"anaesthetic":[1090],"agents":[1091],"intestinal":[1093],"ischemia-reperfusion":[1094],"injury":[1095],"presented.The":[1097],"reviewed":[1098],"strategies":[1099],"involved":[1103],"applications":[1108],"anti-cancer":[1110],"Choi":[1112],"suggested":[1115],"regarded":[1120],"Alzheimer\u2019s":[1126],"(AD)":[1128],"treatments.":[1129,1230],"particular,":[1131],"epidermal":[1138],"growth":[1139],"factor":[1140],"receptor":[1141],"(EGFR)":[1142],"important":[1145,1416],"target":[1147],"AD.":[1152],"EGFR":[1154,1180],"pathway":[1155,1161],"widely":[1158],"recognized":[1159],"oncogenic":[1160],"non-small":[1163],"cell":[1164,1186],"lung":[1165],"focused":[1174],"linkage":[1178],"upregulation":[1181],"migration":[1187],"promotion":[1189],"AD":[1191],"pathology":[1192],"(e.g.,":[1193],"production":[1194],"deposition":[1196],"\u03b2-amyloid":[1199],"peptide,":[1200],"neuroinflammation,":[1201],"cognitive":[1203],"function).We":[1204],"convinced":[1206],"offer":[1212],"manuscripts":[1219],"aiming":[1220],"identify":[1222],"selected":[1224],"specific":[1228,1448],"Repurposing":[1231],"well-known":[1236],"toxicological":[1239],"profile":[1240],"attractive":[1243],"method":[1244],"quickly":[1246],"discovering":[1247],"indications.":[1250],"off-label":[1252],"requires":[1259],"much":[1260],"less":[1261,1282],"capital":[1262],"time,":[1264],"hasten":[1267],"progress":[1268],"Conversely,":[1275],"pharmaceutical":[1276],"industry":[1277],"seems":[1278],"be,":[1280],"historically":[1281],"investing":[1285],"marketed":[1293],"drugs,":[1294],"direct":[1299],"consequence":[1300],"lack":[1303],"economic":[1305],"incentives,":[1306],"decreased":[1310],"chance":[1311],"patent.":[1315],"Then,":[1316],"indications,":[1320],"posologies":[1321],"formulations":[1323],"studied":[1329],"independent":[1332],"being":[1335],"conducted":[1336],"institutes,":[1339],"academia":[1340],"collaborative":[1342],"groups.":[1343],"It":[1344],"then":[1346],"clear":[1347],"additional":[1349,1392],"needed":[1353],"confirm":[1355,1467],"results":[1358],"terms":[1360],"efficacy":[1362],"small":[1368],"I":[1369],"II":[1371],"phase":[1372],"studies,":[1374],"large":[1376],"still":[1378],"too":[1379],"expensive,":[1380],"time-consuming,":[1381],"labor-intensive":[1383],"controlled":[1385],"trials.":[1386],"Therefore":[1387],"some":[1388],"advocate":[1390],"funding":[1394],"harmonization":[1399],"centralization":[1401],"activities":[1406],"(Verbaanderd":[1407],"2021).":[1410],"latter":[1412],"aspect":[1413],"becomes":[1414],"especially":[1415],"light":[1419],"fact":[1422],"circumstances":[1426],"wide":[1435],"areas":[1439],"(even":[1440],"outside":[1441],"compounds":[1449],"for)":[1452],"only,":[1459],"required":[1465],"adoption,":[1474],"certain":[1477],"cases,":[1478],"even":[1480],"higher":[1482],"efficacy,":[1483],"wellbeing":[1487],"thought":[1490],"(Aronson":[1491],"JK,":[1492],"2007;":[1493],"Rechberger":[1494],"JS":[1495],"2025).":[1498]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4408635366","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2025-03-20T00:00:00"}
